UroGen Pharma Ltd (NAS:URGN)
$ 13.05 -0.76 (-5.5%) Market Cap: 549.59 Mil Enterprise Value: 437.91 Mil PE Ratio: 0 PB Ratio: 18.74 GF Score: 72/100

Urogen Pharma Ltd To Host the Spotlight Event Transcript

Nov 10, 2021 / 04:00PM GMT
Release Date Price: $18.5 (-0.80%)
Operator

Hello, and thank you for joining us today for UroGen's Spotlight Event.

We will be making certain forward-looking statements during this program. These may include statements regarding the success and timing of our ongoing and planned clinical trials, data presentations, regulatory filings and future research and development efforts, among other things. These forward-looking statements are based on current information, assumptions and expectations that are subject to change.

Please review the forward-looking statements slide being presented, which will also be accessible on our website in the Investor Relations section at the conclusion of this presentation and the full description of potential risk factors found in our latest SEC filings. You are cautioned not to place undue reliance on these forward-looking statements. UroGen disclaims any obligation to update these statements, content from today's presentations as well as a video replay on our website.

Following this pre-recorded session, we will host a live question-and-answer session with management. Thank you again for

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot